Alanyl-glutamine administration suppresses Th17 and reduces inflammatory reaction in dextran sulfate sodium-induced acute colitis

International Immunopharmacology

Volumn 17, Issue 1, 2013, Pages 1-8

  Hou, Yu Chen ^a   Liu, Jun Jen ^a   Pai, Man Hui ^a   Tsou, Shung Sheng ^b   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TUNGS' TAICHUNG METROHARBOR HOSPITAL   (Taiwan)

Author keywords

Alanyl glutamine; DSS colitis; Immunoglobin G; Interleukin 17; T helper cells

Indexed keywords

ALANYLGLUTAMINE; CYTOKINE; DEXTRAN SULFATE; GLUTAMINE; IMMUNOGLOBULIN G; INTERLEUKIN 17; KERATINOCYTE DERIVED CHEMOKINE; MANNITOL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENTERITIS; INFLAMMATION; MACROPHAGE; MALE; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

EID: 84878486032     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.05.004     Document Type: Article

References (47)

1. Ardizzone S, Bianchi Porro G. Inflammatory bowel disease: new insights into pathogenesis and treatment. J Intern Med 2002;252:475-96. (Pubitemid 35454325)
2. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatorymechanisms of host dialogue with the microbiota. Immunol Rev 2005;206:260-76. (Pubitemid 41105175)
3. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-21. (Pubitemid 46348505)
4. Ihle JN. Cytokine receptor signalling. Nature 1995;377:591-4.
5. O'Shea JJ, Murray PJ. Cytokine signaling modules in inflammatory responses. Immunity 2008;28:477-87. (Pubitemid 351467044)
6. Pizarro TT, Cominelli F. Cytokine therapy for Crohn's disease: advances in translational research. Annu Rev Med 2007;58:433-44. (Pubitemid 46706525)
7. Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B, et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006;116:1310-6.
8. Abraham C, Cho JH. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu Rev Med 2009;60:97-110.
9. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57. (Pubitemid 46722637)
10. Wilmore DW. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001;131:2543S-9S. (Pubitemid 32847007)
11. Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A, Arenas-Marquez H, Cabrera- Pivaral C, Cervantes-Guevara G, et al. L-Alanyl-L-glutamine- supplemented parenteral nutrition improves infectiousmorbidity in secondary peritonitis. Clin Nutr 2004;23: 13-21. (Pubitemid 38219647)
12. Goeters C, Wenn A, Mertes N, Wempe C, Van Aken H, Stehle P, et al. Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients. Crit Care Med 2002;30:2032-7.
13. Fürst P, Albers S, Stehle P. Glutamine-containing dipeptides in parenteral nutrition. J Parenter Enteral Nutr 1990;14:118S-24S.
14. Gianotti L, Alexander JW, Gennari R, Pyles T, Babcock GF. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. J Parenter Enteral Nutr 1995;19:69-74.
15. Wischmeyer PE, Kahana M,Wolfson R, Ren H, Musch MM, Chang EB. Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia. Shock 2001;16:398-402. (Pubitemid 33598218)
16. Yeh SL, Lai YN, Shang HF, Lin MT, Chen WJ. Effects of glutamine supplementation on innate immune response in rats with gut-derived sepsis. Br J Nutr 2004;91: 423-9.
17. Shiomi Y, Nishiumi S, Ooi M, Hatano N, Shinohara M, Yoshie T, et al. GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis 2011;17:2261-74.
18. Vicario M, Amat C, Rivero M, Moreto M, Pelegri C. Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis. J Nutr 2007;137:1931-7. (Pubitemid 47292741)
19. Xue H, Sufit AJ, Wischmeyer PE. Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models. J Parenter Enteral Nutr 2011;35: 188-97.
20. Chu CC, Hou YC, Pai MH, Chao CJ, Yeh SL. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis. J Nutr Biochem 2012;23: 1092-9.
21. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 2005;288:G1328-38. (Pubitemid 40741088)
22. Mok E, Constantin B, Favreau F, Neveux N, Magaud C, Delwail A, et al. L-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice. Pediatr Res 2008;63:268-73. (Pubitemid 351301455)
23. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen TE, Conklin LS, et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009;15:341-52.
24. Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998;114:385-91. (Pubitemid 28539597)
25. Shintani N, Nakajima T, Okamoto T, Kondo T, Nakamura N, Mayumi T. Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action. Gen Pharmacol 1998;31:477-81. (Pubitemid 28398878)
26. Costa VS, Mattana TC, da Silva ME. Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabetes Res Clin Pract 2010;88:222-6.
27. Dieleman LA, Ridwan BU, Tennyson GS, BeagleyKW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994;107:1643-52. (Pubitemid 24357616)
28. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009;31:15-23.
29. Sonnenberg GF, Nair MG, Kirn TJ, Zaph C, Fouser LA, Artis D. Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A. J Exp Med 2010;207:1293-305.
30. Macpherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 1996;38:365-75. (Pubitemid 26074316)
31. Choudari CP, O'Mahony S, Brydon G, Mwantembe O, Ferguson A. Gut lavage fluid protein concentrations: objective measures of disease activity in inflammatory bowel disease. Gastroenterology 1993;104:1064-71. (Pubitemid 23090759)
32. Strieter RM, Kunkel SL, Keane MP, Standiford TJ. Chemokines in lung injury: Thomas A. Neff lecture. Chest 1999;116:103S-10S.
33. Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J Immunol 1999;163:6148-54.
34. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 2002;51:818-26. (Pubitemid 35408603)
35. Li P, Yin YL, Li D, Kim SW, Wu G. Amino acids and immune function. Br J Nutr 2007;98:237-52. (Pubitemid 47091364)
36. Kretzmann NA, Fillmann H, Mauriz JL, Marroni CA, Marroni N, González-Gallego J, et al. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis. Inflamm Bowel Dis 2008;14:1504-13.
37. Yu JC, Jiang ZM, Li DM, Yang NF, M-X B. Alanyl-glutamine preserves hepatic glutathione stores after 5-FU treatment. Clin Nutr 1996;15:261-5.
38. Scheffold A, Murphy KM, Hofer T. Competition for cytokines: T(reg) cells take all. Nat Immunol 2007;8:1285-7. (Pubitemid 350131165)
39. Basivireddy J, JacobM, Balasubramanian KA. Oral glutamine attenuates indomethacininduced small intestinal damage. Clin Sci (Lond) 2004;107:281-9. (Pubitemid 39243887)
40. Fillmann H, Kretzmann NA, San-Miguel B, Llesuy S, Marroni N, González-Gallego J, et al. Glutamine inhibits over-expression of pro-inflammatory genes and downregulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Toxicology 2007;236:217-26. (Pubitemid 46977112)
41. Den Hond E, Hiele M, Peeters M, Ghoos Y, Rutgeerts P. Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease. J Parenter Enteral Nutr 1999;23:7-11. (Pubitemid 29016711)
42. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000;30:78-84. (Pubitemid 30349950)
43. Ockenga J, Borchert K, Stüber E, Lochs H,MannsMP, Bischoff SC. Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease. Eur J Clin Nutr 2005;59:1302-9. (Pubitemid 41655635)
44. Ameho CK, Adjei AA, Harrison EK, Takeshita K, Morioka T, Arakaki Y, et al. Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis. Gut 1997;41:487-93. (Pubitemid 27448780)
45. Israeli E, Berenshtein E, Wengrower D, Aptekar L, Kohen R, Zajicek G, et al. Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage. Dig Dis Sci 2004;49:1705-12. (Pubitemid 39335560)
46. Giris M, Erbil Y, Dogru-Abbasoglu S, Yanik BT, Alis H, Olgac V, et al. The effect of heme oxygenase-1 induction by glutamine on TNBS-induced colitis. The effect of glutamine on TNBS colitis. Int J Colorectal Dis 2007;22:591-9. (Pubitemid 47097030)
47. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: a systematic review of the evidence. Crit Care Med 2002;30: 2022-9.